A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/08/1998	WO1998043482A1 Fibrocyte-based cellular therapy formulations
10/08/1998	WO1998043479A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
10/08/1998	WO1998043478A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998	WO1998043477A1 Ileus treatment method
10/08/1998	WO1998038210A3 Methods and compositions for modulation of vesicular release
10/08/1998	WO1998032849A3 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
10/08/1998	WO1998029069A3 Method for changing the refractive power of an eye
10/08/1998	WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
10/08/1998	WO1998022495A3 De-analoques and derivatives of bradykinin 1-5 fragment(bk1-5) and their retropeptides having antikinin activity and uses thereof
10/08/1998	WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998	WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998	WO1998018930A3 Streptococcus pneumoniae antigens and vaccines
10/08/1998	WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/08/1998	WO1998004692A3 Human neuronatin
10/08/1998	WO1998003661A3 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
10/08/1998	DE19722317C1 New human ryanodin receptor type 3 polypeptide
10/08/1998	DE19713393A1 Flip-Gen und Flip-Protein Flip gene and flip-protein
10/08/1998	CA2286893A1 76 kda, 32 kda, and 50 kda helicobacter polypeptides and corresponding polynucleotide molecules
10/08/1998	CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998	CA2285903A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998	CA2285669A1 Flip gene and flip protein
10/08/1998	CA2285631A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998	CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
10/08/1998	CA2285622A1 Chemokine beta-6
10/08/1998	CA2285565A1 Modified adenoviral fiber and target adenoviruses
10/08/1998	CA2285457A1 Method for oral delivery of proteins
10/08/1998	CA2285452A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998	CA2285447A1 Secreted proteins and polynucleotides encoding them
10/08/1998	CA2285259A1 Sandramycin analogs
10/08/1998	CA2285039A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998	CA2285038A1 Treatment for dutch elm disease
10/08/1998	CA2284846A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
10/08/1998	CA2284736A1 Mycobacterium recombinant vaccines
10/08/1998	CA2284730A1 Methods of modulating p33ing1 mediated apoptosis
10/08/1998	CA2284471A1 Fibrocyte-based cellular therapy formulations
10/08/1998	CA2283934A1 Recombinant protein c and protein s variants
10/08/1998	CA2283834A1 Glucagon-like peptide-1 analogs
10/08/1998	CA2283799A1 Novel human serine carboxypeptidase
10/08/1998	CA2281903A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998	CA2253929A1 Preventive and/or therapeutic agent for kidney diseases
10/07/1998	EP0869181A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
10/07/1998	EP0869180A1 A TNF homologue, TL5
10/07/1998	EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998	EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998	EP0869177A2 Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
10/07/1998	EP0869135A1 Glucagon-like peptide-1 analogs
10/07/1998	EP0868920A2 Hybrid protein for treatment of bladder cancer cells
10/07/1998	EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE
10/07/1998	EP0868521A2 Globins containing binding domains
10/07/1998	EP0868519A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders
10/07/1998	EP0868518A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents
10/07/1998	EP0868516A1 Novel tcts response regulator of staphylococcus aureus
10/07/1998	EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998	EP0868511A1 Utrophin gene expression
10/07/1998	EP0868510A2 P2u2 PURINERGIC RECEPTOR
10/07/1998	EP0868435A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
10/07/1998	EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998	EP0868430A1 Therapeutic compositions
10/07/1998	EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/07/1998	EP0868428A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity
10/07/1998	EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/07/1998	EP0868197A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
10/07/1998	EP0868196A1 Synthetic vaccine for protection against human immunodeficiency virus infection
10/07/1998	EP0868195A2 Control of protein synthesis, and screening method for agents
10/07/1998	EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
10/07/1998	EP0868192A1 Fast drying, film forming iodine release solution
10/07/1998	EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998	EP0837875A4 Inhibitors of farnesyl-protein transferase
10/07/1998	EP0808203A4 Centrifuge with annular filter
10/07/1998	EP0765165A4 Constrained peptides
10/07/1998	EP0703923B1 Factor vii-derived peptides
10/07/1998	EP0654042B1 Amylin muteins
10/07/1998	EP0621867B1 New endothelin antagonists and their preparation
10/07/1998	EP0548123B1 Anti-inflammatory factor, method of isolation, and use
10/07/1998	CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use
10/07/1998	CN1195354A New thrombin inhibitors their preparation and use
10/07/1998	CN1195296A Drug composition comprising albumin as active ingredient
10/07/1998	CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998	CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998	CN1195293A Method for treating disbetes
10/07/1998	CN1194986A Anti-obesity proteins
10/07/1998	CN1040126C Process for preparing protein
10/06/1998	US5817796 C-myb ribozymes having 2'-5'-linked adenylate residues
10/06/1998	US5817790 Reshaped human antibody to human interleukin-6 receptor
10/06/1998	US5817789 Bind to cell surface receptors; genetic engineering
10/06/1998	US5817788 Renders factor viia unable to activate plasma factors x or ix, coagulation-related disorders
10/06/1998	US5817787 Probes and methods for detecting melanocortin-5 receptor
10/06/1998	US5817785 Methods of producing nucleic acid ligands
10/06/1998	US5817784 Polypeptide termined neuritin which is expressed primary in brain tissue
10/06/1998	US5817782 Controlling stability and tolerance of stress; longevityassurance gene
10/06/1998	US5817773 Stimulation, production, culturing and transplantation of stem cells by fibroblast growth factors
10/06/1998	US5817771 Cell-targeted lytic pore-forming agents
10/06/1998	US5817769 Antibodies to mammalian adipogenic factors
10/06/1998	US5817767 Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
10/06/1998	US5817765 Purification of plasma proteins
10/06/1998	US5817763 Cytokine
10/06/1998	US5817762 Mammalian tub protein
10/06/1998	US5817757 Inhibitors of peptide binding to MHO class II proteins
10/06/1998	US5817756 Pseudo- and non-peptide bradykinin receptor antagonists

1 ... 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 ... 3163